Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.59 -0.02 (-0.77%)
As of: Oct 2, 2026 · 11:32 AM EDT

Zentalis Pharmaceuticals (ZNTL) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Zentalis Pharmaceuticals' Liabilities and Shareholders Equity came in at $215.33 million for Q2 2026, down 38.8% from $351.71 million a year earlier and down 14.9% from the prior quarter.

Analysis

Zentalis Pharmaceuticals (ZNTL) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Zentalis Pharmaceuticals' Liabilities and Shareholders Equity was $288.97 million, down 32.9% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $430.34 million in FY2024 (-22.0%), $551.69 million in FY2023 (+2.3%), $539.31 million in FY2022 (+18.7%) and $454.51 million in FY2021 (+24.3%).
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q1 2020.
  • Year-over-year, Liabilities and Shareholders Equity has declined for nine consecutive quarters, with an average decline of 29.7% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q2 2022 (growth of 100.0%), and the weakest in Q2 2026 (a decline of 38.8%).
  • Business Quant data shows ZNTL's Liabilities and Shareholders Equity at $253.07 million (Q1 2026), $288.97 million (Q4 2025) and $327.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Zentalis Pharmaceuticals 198.52 Mn 198.52 Mn - 215.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 215.33 Mn
Mar 31, 2026 253.07 Mn
Dec 31, 2025 288.97 Mn
Sep 30, 2025 327.25 Mn
Jun 30, 2025 351.71 Mn
Mar 31, 2025 384.02 Mn
Dec 31, 2024 430.34 Mn
Sep 30, 2024 450.66 Mn
Jun 30, 2024 491.68 Mn
Mar 31, 2024 557.48 Mn
Dec 31, 2023 551.69 Mn
Sep 30, 2023 585.72 Mn
Jun 30, 2023 621.44 Mn
Mar 31, 2023 489.34 Mn
Dec 31, 2022 539.31 Mn
Sep 30, 2022 529.19 Mn
Jun 30, 2022 567.86 Mn
Mar 31, 2022 405.68 Mn
Dec 31, 2021 454.51 Mn
Sep 30, 2021 435.08 Mn
API Access

Zentalis Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ZNTL&period=max&api_key=YOUR_API_KEY